Asana (ASAN) 10-Q 5 Dec 23 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Oct. 31, 2023	Nov. 28, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2023
Document Transition Report	false
Entity File Number	001-39495
Entity Registrant Name	Asana, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-3912448
Entity Address, Address Line One	633 Folsom Street, Suite 100
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94107
City Area Code	415
Local Phone Number	525-3888
Title of 12(b) Security	Class A Common Stock, $0.00001 par value per share
Trading Symbol	ASAN
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001477720
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	false
Common Class A
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		137,045,378
Common Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		85,489,359

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Current assets
Cash and cash equivalents	$ 268,314	$ 526,563
Marketable securities	261,726	2,739
Accounts receivable, net	68,032	82,363
Prepaid expenses and other current assets	46,069	48,726
Total current assets	644,141	660,391
Property and equipment, net	98,241	94,984
Operating lease right-of-use assets	182,779	176,189
Other assets	22,519	23,399
Total assets	947,680	954,963
Current liabilities
Accounts payable	9,988	7,554
Accrued expenses and other current liabilities	65,698	83,488
Deferred revenue, current	249,673	226,443
Operating lease liabilities, current	17,592	14,831
Total current liabilities	342,951	332,316
Term loan, net	44,856	46,696
Deferred revenue, noncurrent	5,770	7,156
Operating lease liabilities, noncurrent	220,181	210,012
Other liabilities	1,753	2,209
Total liabilities	615,511	598,389
Commitments and contingencies (Note 7)
Stockholders' equity
Common stock	2	2
Additional paid-in capital	1,767,633	1,595,001
Accumulated other comprehensive loss	(3,278)	(873)
Accumulated deficit	(1,432,188)	(1,237,556)
Total stockholders’ equity	332,169	356,574
Total liabilities and stockholders’ equity	$ 947,680	$ 954,963

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Income Statement [Abstract]
Revenues	$ 166,503	$ 141,439	$ 481,369	$ 396,981
Cost of revenues	16,053	15,160	47,132	41,354
Gross profit	150,450	126,279	434,237	355,627
Operating expenses:
Research and development	81,028	75,509	241,715	215,947
Sales and marketing	98,349	113,713	288,034	320,228
General and administrative	34,494	38,165	106,537	128,064
Total operating expenses	213,871	227,387	636,286	664,239
Loss from operations	(63,421)	(101,108)	(202,049)	(308,612)
Interest income and other income (expense), net	3,479	1,291	13,310	(219)
Interest expense	(1,012)	(457)	(2,947)	(1,125)
Loss before provision for income taxes	(60,954)	(100,274)	(191,686)	(309,956)
Provision for income taxes	796	631	2,946	2,786
Net loss	$ (61,750)	$ (100,905)	$ (194,632)	$ (312,742)
Net loss per share:
Basic (in dollars per share)	$ (0.28)	$ (0.49)	$ (0.89)	$ (1.60)
Diluted (in dollars per share)	$ (0.28)	$ (0.49)	$ (0.89)	$ (1.60)
Weighted-average shares used in calculating net loss per share:
Basic (in shares)	221,776	204,657	219,094	195,261
Diluted (in shares)	221,776	204,657	219,094	195,261

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (61,750)	$ (100,905)	$ (194,632)	$ (312,742)
Other comprehensive loss:
Net unrealized gain (losses) on marketable securities	(236)	176	(1,251)	(29)
Change in foreign currency translation adjustments	(1,725)	(1,225)	(1,154)	(2,048)
Comprehensive loss	$ (63,711)	$ (101,954)	$ (197,037)	$ (314,819)

CONDENSED CONSOLIDATED STATMENT

CONDENSED CONSOLIDATED STATMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2022		188,298
Beginning balance at Jan. 31, 2022	$ 203,840	$ 2	$ 1,034,252	$ (626)	$ (829,788)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)		1,599
Issuance of common stock upon the exercise of options	4,607		4,607
Vesting of early exercised stock options	595		595
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)		2,802
Issuance of common stock under employee share purchase plan (in shares)		720
Issuance of common stock under employee share purchase plan	17,115		17,115
Issuance of common stock upon conversion of convertible notes—related party (in shares)		19,273
Issuance of common stock upon conversion of convertible notes—related party	347,288
Stock-based compensation expense	136,343		136,343
Net unrealized gain (losses) on marketable securities	(29)			(29)
Foreign currency translation adjustments	(2,048)			(2,048)
Net loss	(312,742)				(312,742)
Ending balance (in shares) at Oct. 31, 2022		212,692
Ending balance at Oct. 31, 2022	394,969	$ 2	1,540,200	(2,703)	(1,142,530)
Beginning balance (in shares) at Jul. 31, 2022		191,666
Beginning balance at Jul. 31, 2022	92,121	$ 2	1,135,398	(1,654)	(1,041,625)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)		321
Issuance of common stock upon the exercise of options	978		978
Vesting of early exercised stock options	134		134
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)		1,065
Issuance of common stock under employee share purchase plan (in shares)		367
Issuance of common stock under employee share purchase plan	7,959		7,959
Issuance of common stock upon conversion of convertible notes—related party (in shares)		19,273
Issuance of common stock upon conversion of convertible notes—related party	347,288
Stock-based compensation expense	48,443		48,443
Net unrealized gain (losses) on marketable securities	176			176
Foreign currency translation adjustments	(1,225)			(1,225)
Net loss	(100,905)				(100,905)
Ending balance (in shares) at Oct. 31, 2022		212,692
Ending balance at Oct. 31, 2022	394,969	$ 2	1,540,200	(2,703)	(1,142,530)
Beginning balance (in shares) at Jan. 31, 2023		214,293
Beginning balance at Jan. 31, 2023	$ 356,574	$ 2	1,595,001	(873)	(1,237,556)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)	1,649	1,649
Issuance of common stock upon the exercise of options	$ 3,856		3,856
Vesting of early exercised stock options	108		108
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)		5,584
Issuance of common stock upon the vesting and settlement of restricted stock units	(7)
Issuance of common stock under employee share purchase plan (in shares)		878
Issuance of common stock under employee share purchase plan	15,069		15,069
Stock-based compensation expense	153,606		153,606
Net unrealized gain (losses) on marketable securities	(1,251)			(1,251)
Foreign currency translation adjustments	(1,154)			(1,154)
Net loss	(194,632)				(194,632)
Ending balance (in shares) at Oct. 31, 2023		222,404
Ending balance at Oct. 31, 2023	332,169	$ 2	1,767,633	(3,278)	(1,432,188)
Beginning balance (in shares) at Jul. 31, 2023		219,606
Beginning balance at Jul. 31, 2023	334,253	$ 2	1,706,006	(1,317)	(1,370,438)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)		278
Issuance of common stock upon the exercise of options	783		783
Vesting of early exercised stock options	2		2
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)		2,100
Issuance of common stock upon the vesting and settlement of restricted stock units	0
Issuance of common stock under employee share purchase plan (in shares)		420
Issuance of common stock under employee share purchase plan	6,511		6,511
Stock-based compensation expense	54,331		54,331
Net unrealized gain (losses) on marketable securities	(236)			(236)
Foreign currency translation adjustments	(1,725)			(1,725)
Net loss	(61,750)				(61,750)
Ending balance (in shares) at Oct. 31, 2023		222,404
Ending balance at Oct. 31, 2023	$ 332,169	$ 2	$ 1,767,633	$ (3,278)	$ (1,432,188)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Cash flows from operating activities
Net loss	$ (194,632)	$ (312,742)
Adjustments to reconcile net loss to net cash used in operating activities:
Allowance for expected credit losses	2,072	1,045
Depreciation and amortization	10,407	9,507
Amortization of deferred contract acquisition costs	15,971	10,509
Stock-based compensation expense	150,569	135,834
Net amortization (accretion) of premium (discount) on marketable securities	(1,568)	50
Non-cash lease expense	13,998	11,426
Impairment of long-lived assets	5,009	0
Amortization of discount on revolving credit facility and term loan issuance costs	91	13
Changes in operating assets and liabilities:
Accounts receivable	12,251	(1,377)
Prepaid expenses and other current assets	(13,764)	(22,155)
Other assets	742	(3,201)
Accounts payable	3,612	(3,333)
Accrued expenses and other liabilities	(16,885)	15,225
Deferred revenue	21,843	40,614
Operating lease liabilities	(12,310)	(10,374)
Net cash used in operating activities	(2,594)	(128,959)
Cash flows from investing activities
Purchases of marketable securities	(284,312)	(72,216)
Sales of marketable securities	12	0
Maturities of marketable securities	25,641	110,204
Purchases of property and equipment	(7,221)	(3,140)
Capitalized internal-use software costs	(4,325)	(952)
Net cash provided by (used in) investing activities	(270,205)	33,896
Cash flows from financing activities
Repayment of term loan	(2,500)	(2,667)
Proceeds from private placement—related party, net of offering costs	0	347,384
Repurchases of common stock	0	(2)
Proceeds from exercise of stock options	3,856	4,627
Proceeds from employee stock purchase plan	15,069	17,115
Taxes paid related to net share settlement of equity awards	(7)	0
Net cash provided by financing activities	16,418	366,457
Effect of foreign exchange rates on cash, cash equivalents, and restricted cash	(1,868)	(1,207)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(258,249)	270,187
Cash, cash equivalents, and restricted cash
Beginning of period	526,563	240,403
End of period	268,314	510,590
Reconciliation of cash, cash equivalents, and restricted cash to the condensed consolidated balance sheets
Cash and cash equivalents	268,314	509,091
Restricted cash	0	1,499
Supplemental cash flow data
Cash paid for income taxes	3,101	3,617
Supplemental non-cash investing and financing information
Purchase of property and equipment in accounts payable and accrued expenses	286	651
Private placement—related party offering costs not yet paid	$ 0	$ 96

Organization

Organization	9 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization Organization and Description of Business Asana, Inc. (“Asana” or the “Company”) was incorporated in the state of Delaware on December 16, 2008. Asana is a work management platform that helps organizations orchestrate work, from daily tasks to cross-functional strategic initiatives. The Company is headquartered in San Francisco, California.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”) and include the accounts of the Company’s wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated on consolidation. The unaudited condensed consolidated balance sheet as of January 31, 2023 included herein was derived from the audited financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management's opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to state fairly the balance sheet, statements of comprehensive loss, and stockholders' equity (deficit), and statements of cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K filed with the SEC on March 24, 2023. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. Estimates and assumptions reflected in the consolidated financial statements include, but are not limited to, revenue recognition, the useful lives and carrying values of long-lived assets, the fair value of common stock for periods prior to the Company’s direct listing of its Class A common stock on the New York Stock Exchange (“NYSE”) (the “Direct Listing”), stock-based compensation expense, the period of benefit for deferred contract acquisition costs, income taxes, and the valuation of right-of-use assets. Actual results could differ from those estimates. Risks and Uncertainties Global macroeconomic events including elevated inflation, the U.S. Federal Reserve raising interest rates, bank failures, supply chain disruptions, fluctuations in currency exchange rates, the Russian invasion of Ukraine, the current armed conflict in Israel and the Gaza Strip, and the residual impact of the COVID-19 pandemic have led to economic uncertainty. These macroeconomic conditions have and are likely to continue to have adverse effects on the rate of global IT spending, including the buying patterns of the Company’s customers and prospective customers. The conditions caused by the aforementioned macroeconomic events have affected and could continue to affect the rate of global IT spending and could adversely affect demand for the Company’s platform, lengthen the Company’s sales cycles, reduce the value or duration of subscriptions, negatively impact collections of accounts receivable, reduce expected spending from new customers, cause some of the Company’s paying customers to go out of business, and affect contraction or attrition rates of the Company’s customers, all of which could adversely affect the Company’s business, results of operations, and financial condition. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance related to the aforementioned macroeconomic events that would require it to update its estimates or judgments or adjust the carrying value of its assets or liabilities. Actual results could differ from those estimates and any such differences may be material to the condensed consolidated financial statements. Concentration of Credit Risk Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents, and marketable securities. The Company deposits its cash and cash equivalents with financial institutions that management believes are of high credit quality, although such deposits may, at times, exceed federally insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents to date. Cash equivalents are invested in highly rated securities. The Company grants credit to customers in the normal course of business. For the three and nine months ended October 31, 2023 and October 31, 2022, there were no individual customers that accounted for 10% or more of the Company’s revenues. No customer accounted for more than 10% of accounts receivable as of October 31, 2023 or January 31, 2023. Fair Value of Financial Instruments Fair value is defined as the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the reporting date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. Fair value is estimated by utilizing a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1—Observable inputs comprised of quoted prices for identical assets or liabilities in active markets. Level 2—Inputs other than the quoted prices in active markets that are observable either directly or indirectly. Level 3—Unobservable inputs in which there is little or no market data and that are significant to the fair value of the assets or liabilities. In determining fair value, a financial instrument’s classification within the three-tier fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value. The carrying amount of certain financial instruments, including cash, accounts receivable, accounts payable, and accrued liabilities approximates their fair values due to their short-term nature. Available-for-sale Investments The Company’s marketable securities are primarily comprised of U.S. government securities, commercial paper, and corporate bonds. The Company classifies its securities as available-for-sale at the time of purchase and reevaluates such classification at each balance sheet date. The Company may sell these securities at any time for use in current operations even if they have not yet reached maturity. As a result, the Company classifies its marketable securities, including securities with stated maturities beyond twelve months, within current assets in the condensed consolidated balance sheets. Available-for-sale securities are carried at fair value with unrealized gains and losses reported in accumulated other comprehensive income (loss) as a separate component of stockholders’ equity (deficit) until realized. Unrealized gains and losses for any marketable securities that management intends to sell or is more likely than not that management will be required to sell prior to their anticipated recovery are recorded in other income (expense), net. Impairment of Long-Lived Assets The Company evaluates its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such asset groups may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset group to future undiscounted cash flows expected to be generated by the asset group. If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. The Company recorded no impairment charge during the three months ended October 31, 2023 and 2022. The Company recorded $5.0 million and no impairment charge during the nine months ended October 31, 2023 and 2022, respectively. The $5.0 million impairment charge incurred during the nine months ended October 31, 2023 related to the right-of-use (“ROU”) assets and underlying property and equipment associated with the Company’s subleased office spaces is further described in Note 8. Leases to the condensed consolidated financial statements. Recently Adopted Accounting Pronouncements On February 1, 2023, the Company adopted ASU No. 2021-08 , Business Combinations - Accounting for Contract Liabilities from Contracts with Customers, which requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities from acquired contracts using the revenue recognition guidance under Accounting Standards Codification Topic 606 in order to align the recognition of a contract liability with the definition of a performance obligation.

Revenues

Revenues	9 Months Ended
	Oct. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenues	Revenues Deferred Revenue and Remaining Performance Obligations The Company recognized $42.5 million and $32.1 million of revenues during the three months ended October 31, 2023 and 2022, respectively, that were included in the deferred revenue balances at January 31, 2023 and 2022, respectively. The Company recognized $208.6 million and $156.3 million of revenues during the nine months ended October 31, 2023 and 2022, respectively, that were included in the deferred revenue balances at January 31, 2023 and 2022, respectively. Deferred revenue that will be recognized within the next twelve months is recorded as current deferred revenue, and the remaining portion is recorded as noncurrent. As of October 31, 2023, the Company's remaining performance obligations from subscription contracts was $335.1 million, of which the Company expects to recognize approximately 85% as revenues over the next 12 months and the remainder thereafter. Deferred Contract Acquisition Costs Deferred contract acquisition costs are amortized over a period of benefit of three years. The period of benefit was estimated by considering factors such as historical customer attrition rates, the useful life of the Company’s technology, and the impact of competition in the software-as-a-service industry. The following table summarizes the activity of deferred contract acquisition costs (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Beginning balance $ 38,336 $ 28,227 $ 36,583 $ 22,771 Capitalization of contract acquisition costs 5,277 7,399 17,333 19,427 Amortization of deferred contract acquisition costs (5,668) (3,937) (15,971) (10,509) Ending balance $ 37,945 $ 31,689 $ 37,945 $ 31,689 Deferred contract acquisition costs, current $ 20,528 $ 15,513 $ 20,528 $ 15,513 Deferred contract acquisition costs, noncurrent 17,417 16,176 17,417 16,176 Total deferred contract acquisition costs $ 37,945 $ 31,689 $ 37,945 $ 31,689 Deferred contract acquisition costs, current is presented within prepaid expenses and other current assets in the condensed consolidated balance sheets. Deferred contract acquisition costs, noncurrent is presented within other assets in the condensed consolidated balance sheets.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table summarizes, for assets and liabilities measured at fair value, the respective fair value and classification by level of input within the fair value hierarchy (in thousands): October 31, 2023 Level 1 Level 2 Level 3 Total Current Assets Cash equivalents Money market funds $ 82,400 $ — $ — $ 82,400 Commercial paper — 4,959 — 4,959 U.S. government agency securities 9,950 — — 9,950 Total cash equivalents $ 92,350 $ 4,959 $ — $ 97,309 Marketable securities U.S. government agency securities $ 157,746 $ — $ — $ 157,746 Commercial paper — 11,463 — 11,463 Corporate bonds — 71,279 — 71,279 Agency bonds — 21,238 — 21,238 Total marketable securities $ 157,746 $ 103,980 $ — $ 261,726 Total assets $ 250,096 $ 108,939 $ — $ 359,035 January 31, 2023 Level 1 Level 2 Level 3 Total Current Assets Cash equivalents Money market funds $ 289,001 $ — $ — $ 289,001 Total cash equivalents $ 289,001 $ — $ — $ 289,001 Marketable securities Corporate bonds $ — $ 2,739 $ — $ 2,739 Total marketable securities $ — $ 2,739 $ — $ 2,739 Total assets $ 289,001 $ 2,739 $ — $ 291,740 The following table summarizes the Company's investments in marketable securities on the condensed consolidated balance sheets (in thousands): October 31, 2023 Amortized Gross Gross Unrealized Losses Estimated Current Assets U.S. government agency securities $ 158,742 $ 4 $ (1,000) $ 157,746 Commercial paper 11,472 — (9) 11,463 Corporate bonds 71,518 35 (274) 71,279 Agency bonds 21,250 — (12) 21,238 Total marketable securities $ 262,982 $ 39 $ (1,295) $ 261,726 January 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Current Assets Corporate bonds $ 2,744 $ — $ (5) $ 2,739 Total marketable securities $ 2,744 $ — $ (5) $ 2,739 The following table presents the contractual maturities of the Company’s marketable securities as of October 31, 2023 (in thousands): October 31, 2023 Amortized Cost Estimated Fair Value Due within one year $ 116,425 $ 116,219 Due within one to three years 146,557 145,507 Total $ 262,982 $ 261,726 The Company periodically evaluates its investments for expected credit losses. The unrealized losses on the available-for-sale securities were primarily due to unfavorable changes in interest rates subsequent to the initial purchase of these securities. Gross unrealized losses of the Company’s available-for-sale securities that have been in a continuous unrealized loss position for twelve months or longer were immaterial as of October 31, 2023 and January 31, 2023. The Company expects to recover the full carrying value of its available-for-sale securities in an unrealized loss position as it does not intend or anticipate a need to sell these securities prior to recovering the associated unrealized losses. The Company also expects any credit losses would be immaterial based on the high-grade credit rating for each of such available-for-sale securities. As a result, the Company does not consider any portion of the unrealized losses as of October 31, 2023 or January 31, 2023 to represent credit losses. In April 2020 and November 2022, the Company entered into credit agreements (the “April 2020 Senior Secured Term Loan” and “November 2022 Senior Secured Credit Facility” as defined in Note 6. Debt ) with Silicon Valley Bank (“SVB”). The fair values of the credit facilities approximated their carrying values as of October 31, 2023 and January 31, 2023. On March 27, 2023, First Citizens BancShares, Inc. announced that it entered into an agreement to purchase assets and liabilities of SVB, inclusive of the November 2022 Senior Secured Credit Facility.

Balance Sheet Components

Balance Sheet Components	9 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components Property and Equipment, Net Property and equipment, net, consisted of the following (in thousands): October 31, 2023 January 31, 2023 Leasehold improvements $ 100,733 $ 98,264 Capitalized internal-use software 22,203 15,005 Furniture and fixtures 11,676 10,325 Desktop and other computer equipment 2,106 1,804 Construction in progress 26 652 Total gross property and equipment 136,744 126,050 Less: Accumulated depreciation and amortization (38,503) (31,066) Total property and equipment, net $ 98,241 $ 94,984 Depreciation and amortization expense was $3.5 million and $3.2 million for the three months ended October 31, 2023 and 2022, respectively, and $10.4 million and $9.5 million for the nine months ended October 31, 2023 and 2022, respectively. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): October 31, 2023 January 31, 2023 Deferred contract acquisition costs, current $ 20,528 $ 18,049 Prepaid expenses 20,305 25,134 Other current assets 5,236 5,543 Total prepaid expenses and other current assets $ 46,069 $ 48,726 Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): October 31, 2023 January 31, 2023 Accrued payroll liabilities $ 12,972 $ 22,336 Accrued sales and value-added taxes 10,309 13,347 Accrued taxes for fringe benefits 8,509 8,064 Accrued advertising expenses 7,522 10,565 Accrued consulting expenses 3,263 4,076 Other liabilities 23,123 25,100 Total accrued expenses and other current liabilities $ 65,698 $ 83,488

Debt

Debt	9 Months Ended
	Oct. 31, 2023
Debt Disclosure [Abstract]
Debt	Debt In April 2020, the Company entered into a five-year $40.0 million term loan agreement with SVB (the “April 2020 Senior Secured Term Loan”) which provided for a senior secured term loan facility, in an aggregate principal amount of up to $40.0 million to be used for the construction of the Company’s corporate headquarters. Interest accrued and was payable monthly based on a floating rate per annum equal to the prime rate (per the Wall Street Journal) plus an applicable margin ranging from 0% to (1.0)% based on the Company’s unrestricted cash balance at the lender. The April 2020 Senior Secured Term Loan was repaid in full and terminated in November 2022. In November 2022, the Company entered into an agreement for a four-year credit facility (as amended on April 13, 2023, the “November 2022 Senior Secured Credit Facility”) with SVB, which refinanced the April 2020 Senior Secured Term Loan. The November 2022 Senior Secured Credit Facility provides for senior secured credit facilities in the aggregate principal amount of $150.0 million, including a senior secured term loan facility in an aggregate principal amount of $50.0 million and a revolving loan facility in an aggregate principal amount of up to $100.0 million, including a $30.0 million letter of credit sub-facility, maturing on November 7, 2026. On March 27, 2023, First Citizens BancShares, Inc. announced that it entered into an agreement to purchase assets and liabilities of SVB, inclusive of the November 2022 Senior Secured Credit Facility. Borrowings under the November 2022 Senior Secured Credit Facility may be designated as ABR Loans or SOFR Loans, subject to certain terms and conditions under the agreement. ABR Loans accrue interest at a rate per annum equal to the ABR plus an applicable margin of 1.25%. Term SOFR Loans accrue interest at a rate per annum equal to the applicable adjusted term SOFR rate, which is equal to the applicable term SOFR rate plus a term SOFR adjustment of 10 basis points, provided such adjusted term SOFR rate shall not be less than zero, plus an applicable margin of 2.25%. Interest accrues and is payable on a monthly basis. The November 2022 Senior Secured Credit Facility contains customary conditions to borrowing, events of default, and covenants, including covenants that restrict the Company’s ability to incur indebtedness, make or hold investments, execute certain change of control transactions, business combinations or other fundamental changes to the business, dispose of assets, make certain types of restricted payments or enter into certain related party transactions, subject to customary exceptions. In addition, the November 2022 Senior Secured Credit Facility contains financial covenants, including a consolidated adjusted quick ratio of 1.25 to 1.00, as well as a minimum cash adjusted EBITDA, each tested on a quarterly basis. Pursuant to the terms of the November 2022 Senior Secured Credit Facility, the Company may issue letters of credit which may reduce the total amount available for borrowing under the revolving credit facility. Additionally, the Company is required to pay an annual commitment fee that accrues at a rate of 0.15% per annum on the unused portion of the borrowing commitments under the revolving credit facility. The Company had an aggregate of $21.4 million of letters of credit outstanding under the revolving credit facility as of October 31, 2023, and the Company’s total available borrowing capacity under the revolving credit facility was $78.6 million as of October 31, 2023. As of October 31, 2023, $50.0 million was drawn and $47.5 million was outstanding under the November 2022 Senior Secured Credit Facility. As of October 31, 2023, the Company was in compliance with all financial covenants. In conjunction with the close of the November 2022 Senior Secured Credit Facility, the Company paid upfront issuance fees of $0.4 million. The upfront fees are amortized over the remaining term of the agreement. As of October 31, 2023, the Company had $0.2 million remaining of upfront issuance fees allocated to the revolving credit facility presented in the Company’s condensed consolidated balance sheet within other assets. The net carrying amounts of the November 2022 Senior Secured Credit Facility were as follows (in thousands): October 31, 2023 January 31, 2023 Principal $ 47,500 $ 50,000 Accrued interest 301 218 Unamortized loan issuance costs (144) (179) Net carrying amount $ 47,657 $ 50,039 Term loan, current $ 2,801 $ 3,343 Term loan, noncurrent $ 44,856 $ 46,696 The net carrying amount of the current portion of the term loan is presented within accrued expenses and other current liabilities in the condensed consolidated balance sheets.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Standby Letters of Credit As of October 31, 2023, the Company had several letters of credit outstanding related to its operating leases totaling $21.4 million . The letters of credit expire at various dates between 2025 and 2034. Purchase Commitments In January 2021, the Company entered into a 60-month contract with Amazon Web Services for hosting-related services. Pursuant to the terms of the contract, the Company is required to spend a minimum of $103.5 million over the term of the agreement. The commitment may be offset by up to $7.3 million in additional credits subject to the Company meeting certain conditions of the agreement, all of which have been earned as of October 31, 2023. As of October 31, 2023, the Company had purchase commitments remaining of $42.3 million under this contract . During the nine months ended October 31, 2023, other than certain non-cancelable operating leases described in Note 8. Leases and the commitment for hosting-related services described above, there have been no other material changes outside the ordinary course of business to the Company's contractual obligations and commitments from those disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2023. Indemnification Agreements The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against any liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual. Additionally, in the ordinary course of business, the Company enters into agreements of varying scope and terms pursuant to which it agrees to indemnify customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. For the three and nine months ended October 31, 2023 and 2022, no demands have been made upon the Company to provide indemnification under such agreements, and there are no claims that the Company is aware of that could have a material adverse effect on its financial position, results of operations, or cash flows. Contingencies From time to time in the normal course of business, the Company may be subject to various claims and other legal matters arising in the ordinary course of business. As of October 31, 2023, the Company believes that none of its current legal proceedings would have a material adverse effect on its financial position, results of operations, or cash flows.

Leases

Leases	9 Months Ended
	Oct. 31, 2023
Leases [Abstract]
Leases	Leases The Company leases real estate facilities under non-cancelable operating leases with various expiration dates through fiscal 2034. The Company has no lease agreements that are classified as finance leases. Future minimum lease payments (net of tenant improvement receivables) under non-cancelable operating leases with initial lease terms in excess of one year included in the Company’s lease liabilities as of October 31, 2023 are as follows (in thousands): Fiscal year ending January 31, Operating Lease Payments (Net) 2024 $ 9,751 2025 39,469 2026 37,707 2027 38,075 2028 and thereafter 238,501 Total undiscounted operating lease payments $ 363,503 Less: imputed interest (125,730) Total operating lease liabilities $ 237,773 During the nine months ended October 31, 2023, the Company executed a sublease for a portion of its corporate office space in San Francisco, California. The Company evaluated the associated asset group for impairment, which included the ROU assets and underlying property and equipment for the lease. The Company compared the expected future undiscounted cash flows to the carrying value and determined the respective asset group was not recoverable. The Company calculated the fair value based on the present value of the estimated cash flows from the sublease for the remaining lease term and compared the estimated fair value to its carrying value, which resulted in a $5.0 million consolidated impairment charge. The fair value of the operating lease ROU assets and associated property and equipment was estimated as of the sublease execution date using level 3 inputs based on an income approach by converting future sublease cash inflows and outflows to a single present value. Estimated cash flows were discounted at a rate commensurate with the inherent risks associated with the asset group to arrive at an estimate of fair value. The impairment charge was included in general and administrative expenses in the condensed consolidated statements of operations. The sublease commenced during the three months ended October 31, 2023 and has a lease term of five years. The Company has classified the sublease as an operating lease. Sublease income was $0.4 million for the three and nine months ended October 31, 2023. There was no sublease income for the three and nine months ended October 31, 2022. The Company recognizes sublease income as a reduction of lease expense in the Company’s condensed consolidated statements of operations. Operating lease amounts in the table above do not include sublease income payments of $8.7 million. As of October 31, 2023, the future total minimum sublease payments to be received were as follows (in thousands): Fiscal year ending January 31, Sublease Payments to be Received 2024 $ — 2025 1,556 2026 1,919 2027 1,976 2028 and thereafter 3,244 Total sublease income $ 8,695
Lessor, Operating Leases	Leases The Company leases real estate facilities under non-cancelable operating leases with various expiration dates through fiscal 2034. The Company has no lease agreements that are classified as finance leases. Future minimum lease payments (net of tenant improvement receivables) under non-cancelable operating leases with initial lease terms in excess of one year included in the Company’s lease liabilities as of October 31, 2023 are as follows (in thousands): Fiscal year ending January 31, Operating Lease Payments (Net) 2024 $ 9,751 2025 39,469 2026 37,707 2027 38,075 2028 and thereafter 238,501 Total undiscounted operating lease payments $ 363,503 Less: imputed interest (125,730) Total operating lease liabilities $ 237,773 During the nine months ended October 31, 2023, the Company executed a sublease for a portion of its corporate office space in San Francisco, California. The Company evaluated the associated asset group for impairment, which included the ROU assets and underlying property and equipment for the lease. The Company compared the expected future undiscounted cash flows to the carrying value and determined the respective asset group was not recoverable. The Company calculated the fair value based on the present value of the estimated cash flows from the sublease for the remaining lease term and compared the estimated fair value to its carrying value, which resulted in a $5.0 million consolidated impairment charge. The fair value of the operating lease ROU assets and associated property and equipment was estimated as of the sublease execution date using level 3 inputs based on an income approach by converting future sublease cash inflows and outflows to a single present value. Estimated cash flows were discounted at a rate commensurate with the inherent risks associated with the asset group to arrive at an estimate of fair value. The impairment charge was included in general and administrative expenses in the condensed consolidated statements of operations. The sublease commenced during the three months ended October 31, 2023 and has a lease term of five years. The Company has classified the sublease as an operating lease. Sublease income was $0.4 million for the three and nine months ended October 31, 2023. There was no sublease income for the three and nine months ended October 31, 2022. The Company recognizes sublease income as a reduction of lease expense in the Company’s condensed consolidated statements of operations. Operating lease amounts in the table above do not include sublease income payments of $8.7 million. As of October 31, 2023, the future total minimum sublease payments to be received were as follows (in thousands): Fiscal year ending January 31, Sublease Payments to be Received 2024 $ — 2025 1,556 2026 1,919 2027 1,976 2028 and thereafter 3,244 Total sublease income $ 8,695

Net Loss per Share

Net Loss per Share	9 Months Ended
	Oct. 31, 2023
Earnings Per Share [Abstract]
Net Loss per Share	Net Loss per Share The Company computes net loss per share using the two-class method required for multiple classes of common stock and participating securities. The rights, including the liquidation and dividend rights, of the Class A common stock and Class B common stock are substantially identical, other than voting rights. Accordingly, the Class A common stock and Class B common stock share equally in the Company’s net income and losses. The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Numerator: Net loss $ (61,750) $ (100,905) $ (194,632) $ (312,742) Denominator: Weighted-average shares used in calculating net loss per share, basic and diluted 221,776 204,657 219,094 195,261 Net loss per share, basic and diluted $ (0.28) $ (0.49) $ (0.89) $ (1.60) The potential shares of common stock that were excluded from the computation of diluted net loss per share for the period presented because including them would have been anti-dilutive are as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Stock options 10,242 12,405 10,242 12,405 Restricted stock units 17,970 12,048 17,970 12,048 Early exercised stock options — 55 — 55 Shares issuable pursuant to the 2020 Employee Stock Purchase Plan 161 160 161 160 Total 28,373 24,668 28,373 24,668

Stockholders' Deficit

Stockholders' Deficit	9 Months Ended
	Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stockholders' Deficit	Stockholders’ Deficit Common Stock There are two classes of common stock that total 1,500,000,000 authorized shares: 1,000,000,000 authorized shares of Class A common stock and 500,000,000 authorized shares of Class B common stock. The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to 10 votes per share and is convertible into one share of Class A common stock. There were 136,915,067 shares of Class A common stock and 85,489,359 shares of Class B common stock issued and outstanding as of October 31, 2023. There were 128,803,395 shares of Class A common stock and 85,489,359 shares of Class B common stock outstanding as of January 31, 2023. All changes in the number of shares of common stock outstanding for the three and nine months ended October 31, 2023 and 2022, were related to changes in Class A common stock. Private Placement—Related Party In September 2022, the Company issued and sold 19,273,127 shares of its Class A common stock to the Company’s CEO in a private placement transaction at a purchase price of $18.16 per share, based on the closing trading price of the Company’s Class A common stock on September 2, 2022, for aggregate gross proceeds of approximately $350 million. The Company incurred issuance costs related to the private placement of $2.7 million. Stock Plans The Company has a 2009 Stock Plan (the “2009 Plan”), a 2012 Amended and Restated Stock Plan (the “2012 Plan”), and a 2020 Equity Incentive Plan (the “2020 Plan”). Each plan was initially established to grant equity awards to employees and consultants of the Company to assist in attracting, retaining, and motivating employees and consultants and to provide incentives to promote the success of the Company’s business. The number of shares reserved for issuance under the 2020 Plan increased by 9,414,923 shares of Class A common stock on February 1, 2022 and increased by 10,714,637 shares of Class A common stock on February 1, 2023 pursuant to the evergreen provisions of the 2020 Plan. There are no outstanding awards under the 2009 Plan, and new issuances under the 2012 Plan terminated upon completion of the Direct Listing. Awards outstanding under the 2012 Plan continue to be outstanding and are governed by the provisions of the 2012 Plan. The 2020 Plan provides for the grant of incentive stock options (“ISOs”), within the meaning of Section 422 of the Code, nonstatutory stock options (“NSOs”), stock appreciation rights, restricted stock awards (“RSUs”), performance-based stock awards, and other forms of equity compensation. ISOs may be granted only to Company employees (including officers and directors who are also employees). NSOs may be granted to Company employees and consultants. Options under the 2020 Plan may be granted for periods of up to 10 years. The exercise price of ISOs and NSOs shall not be less than 100% of the estimated fair value of the shares on the date of grant as determined by the Company’s board of directors (the “Board of Directors”). Options granted generally vest over four years and vest at a rate of 25% upon the first anniversary of the vesting commencement date and 1/48 per month thereafter. The Company has outstanding RSU awards issued pursuant to the 2012 Plan and 2020 Plan. RSUs granted generally vest on a predefined rate over a period of four years contingent upon continuous service. Shares of common stock purchased under the 2012 Plan are subject to certain restrictions and repurchase rights. Stock Options Option activity under the Company’s combined stock plans is set forth below (in thousands, except years and per share data): Number of Shares Weighted- Average Exercise Price Weighted- Aggregate Intrinsic Value Balances at January 31, 2023 11,941 $ 2.96 5.1 $ 149,738 Options granted — — Options exercised (1,649) 2.34 Options cancelled (50) 5.42 Balances at October 31, 2023 10,242 $ 3.05 4.4 $ 157,956 Vested and exercisable at October 31, 2023 9,978 $ 3.05 4.4 $ 153,882 Vested and expected to vest at October 31, 2023 10,242 $ 3.05 4.4 $ 157,961 The total intrinsic value of options exercised during the periods presented was as follows: Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Aggregate intrinsic value of options exercised (in thousands) $ 4,583 $ 6,531 $ 30,876 $ 47,586 Early Exercise of Employee Options The 2009 Plan and 2012 Plan allow for the early exercise of stock options. The consideration received for an early exercise of an option is considered to be a deposit of the exercise price, and the related dollar amount is recorded as a liability and reflected in accrued expenses and other current liabilities and other liabilities in the condensed consolidated balance sheets. This liability is reclassified to additional paid-in capital as the awards vest. If a stock option is early exercised, the unvested shares may be repurchased by the Company in case of employment termination at the price paid by the purchaser for such shares. Shares that were subject to repurchase totaled 96 and 55,351 at October 31, 2023 and 2022, respectively. Restricted Stock Units The Company’s RSU activity is set forth below (in thousands, except per share data): Number of Shares Weighted- Average Grant Date Fair Value Aggregate Intrinsic Value Unvested RSUs at January 31, 2023 14,591 $ 27.75 $ 226,145 RSUs granted 11,831 20.18 RSUs vested (5,582) 26.09 RSUs cancelled/forfeited (2,870) 26.12 Unvested RSUs at October 31, 2023 17,970 $ 23.54 $ 331,906 RSUs vested, not yet released at October 31, 2023 856 $ 36.06 Stock-Based Compensation Expense Stock-based compensation for stock-based awards to employees and non-employees in the Company’s condensed consolidated statements of operations for the periods below were as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Cost of revenues $ 413 $ 461 $ 1,177 $ 1,200 Research and development 29,384 25,030 83,928 70,606 Sales and marketing 15,584 15,018 43,438 43,028 General and administrative 7,485 7,482 22,026 21,000 Total stock-based compensation expense $ 52,866 $ 47,991 $ 150,569 $ 135,834 The stock-based compensation expense related to options granted to non-employees for the three and nine months ended October 31, 2023 and 2022 were not material. Total unrecognized compensation costs related to unvested awards not yet recognized under all equity compensation plans was as follows: October 31, 2023 Unrecognized Expense Weighted-Average Expected Recognition Period Stock options $ 383 3.5 RSUs 389,817 3.0 Total unrecognized stock-based compensation expense $ 390,200 3.0 2020 Employee Stock Purchase Plan In September 2020, the Board of Directors adopted and approved the 2020 Employee Stock Purchase Plan (“ESPP”), which became effective on the effective date of the Company's registration statement on Form S-1 filed with the SEC in connection with the Direct Listing. The ESPP initially reserved and authorized the issuance of up to a total of 2,000,000 shares of Class A common stock to participating employees. The number of shares reserved under the ESPP was automatically increased on February 1, 2021 to 3,614,801 shares of Class A common stock, to 5,497,785 on February 1, 2022, and to 7,640,712 on February 1, 2023 pursuant to the evergreen provisions of the ESPP. Subject to any limitations contained therein, the ESPP allows eligible participants to contribute, through payroll deductions, up to 15% of their eligible compensation to purchase shares of the Company’s Class A common stock at a purchase price equal to 85% of the fair market value of the Class A common stock on either the first day of the offering period or the purchase date, whichever fair market value is lower. The ESPP generally provides for consecutive 24-month offering periods, each consisting of four separate consecutive purchase periods of approximately six months in length. The ESPP also includes a two year look back in purchase price, including a reset feature. The reset feature is triggered if the price on the date of purchase is less than the price on the first day of the offering period. The Company recognized stock-based compensation expense related to the ESPP of $4.5 million and $4.3 million during the three months ended October 31, 2023 and 2022, respectively, and $7.8 million and $8.0 million during nine months ended October 31, 2023 and 2022, respectively. As of October 31, 2023 and January 31, 2023, $2.5 million and $6.9 million, respectively, have been withheld in contributions from employees. As of October 31, 2023, total unrecognized compensation cost related to the ESPP was $14.8 million, which will be amortized over a weighted average vesting term of 1.2 years.

Interest Income and Other Incom

Interest Income and Other Income (Expense), Net	9 Months Ended
	Oct. 31, 2023
Other Income and Expenses [Abstract]
Interest Income and Other Income (Expense), Net	Interest Income and Other Income (Expense), Net Interest income and other income (expense), net consist of the following (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Interest income $ 6,088 $ 2,264 $ 15,703 $ 3,007 Unrealized losses on foreign currency transactions (1,545) (211) (1,129) (602) Other non-operating expense (1,064) (762) (1,264) (2,624) Total interest income and other income (expense), net $ 3,479 $ 1,291 $ 13,310 $ (219) Other non-operating expense consists primarily of realized foreign currency gains and losses on transactions in the periods presented.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesThe Company's income tax expense was $0.8 million and $0.6 million for the three months ended October 31, 2023 and 2022, respectively, and $2.9 million and $2.8 million for the nine months ended October 31, 2023 and 2022, respectively, primarily due to income taxes in foreign jurisdictions.

Geographic Information

Geographic Information	9 Months Ended
	Oct. 31, 2023
Segment Reporting [Abstract]
Geographic Information	Geographic Information The following tables set forth revenues and long-lived assets, including operating lease ROU assets, by geographic area for the periods presented below (in thousands): Revenues Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 United States $ 101,019 $ 85,976 $ 293,234 $ 238,600 International 65,484 55,463 188,135 158,381 Total revenues $ 166,503 $ 141,439 $ 481,369 $ 396,981 Revenues by geography are based on the billing address of the customer. Long-Lived Assets October 31, 2023 January 31, 2023 United States $ 275,111 $ 265,582 International 5,909 5,591 Total long-lived assets $ 281,020 $ 271,173

Restructuring

Restructuring	9 Months Ended
	Oct. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring On November 15, 2022, the Company authorized a plan to reduce its global headcount by approximately 9%. This plan was adopted as part of a restructuring intended to improve operational efficiencies and operating costs and better align the Company’s workforce with current business needs, top strategic priorities, and key growth opportunities. The Company has completed payments associated with these restructuring charges in the nine months ended October 31, 2023 and did not incur any restructuring costs during the three and nine months ended October 31, 2023 and 2022. The following table summarizes the Company’s restructuring liabilities (in thousands): Restructuring Liability Beginning balance as of February 1, 2023 $ 873 Charges (benefit) (147) Payments (707) Foreign currency translation adjustment (19) Ending balance as of October 31, 2023 $ —

Related Party Transactions

Related Party Transactions	9 Months Ended
	Oct. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions During the fiscal year ended January 31, 2020, the Company began leasing certain office facilities from a company affiliated with Board members of the Company. Rent expenses under these leases totaled $0.3 million and $0.5 million during the three months ended October 31, 2023 and 2022, respectively, and $1.2 million and $1.4 million during the nine months ended October 31, 2023 and 2022, respectively. The Company has entered into an advertising agreement with a company affiliated with a Board member of the Company. Expenses under this agreement totaled $0.3 million and $0.5 million during the three months ended October 31, 2023 and 2022, respectively, and $0.8 million and $1.5 million during the nine months ended October 31, 2023 and 2022, respectively. The Company has entered into an advertising agreement with a company affiliated with a Board member of the Company. Expenses under this agreement totaled $0.5 million and $0.7 million during the three months ended October 31, 2023 and 2022, respectively, and $1.5 million and $2.5 million during the nine months ended October 31, 2023 and 2022, respectively.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Pay vs Performance Disclosure
Net loss	$ (61,750)	$ (100,905)	$ (194,632)	$ (312,742)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Oct. 31, 2023 shares	Oct. 31, 2023 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false
Justin Rosenstein [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On September 27, 2023, Justin Rosenstein, a member of our board of directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 2,000,000 shares of the Company’s Class A common stock. The plan terminates on January 3, 2025, or upon the earlier completion of all authorized transactions under the plan.
Name	Justin Rosenstein
Title	member of our board of directors
Rule 10b5-1 Arrangement Adopted	true
Arrangement Duration	464 days
Aggregate Available	2,000,000	2,000,000

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”) and include the accounts of the Company’s wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated on consolidation.
Basis of Accounting	The unaudited condensed consolidated balance sheet as of January 31, 2023 included herein was derived from the audited financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management's opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to state fairly the balance sheet, statements of comprehensive loss, and stockholders' equity (deficit), and statements of cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K filed with the SEC on March 24, 2023.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. Estimates and assumptions reflected in the consolidated financial statements include, but are not limited to, revenue recognition, the useful lives and carrying values of long-lived assets, the fair value of common stock for periods prior to the Company’s direct listing of its Class A common stock on the New York Stock Exchange (“NYSE”) (the “Direct Listing”), stock-based compensation expense, the period of benefit for deferred contract acquisition costs, income taxes, and the valuation of right-of-use assets. Actual results could differ from those estimates.
Risks and Uncertainties	Risks and Uncertainties Global macroeconomic events including elevated inflation, the U.S. Federal Reserve raising interest rates, bank failures, supply chain disruptions, fluctuations in currency exchange rates, the Russian invasion of Ukraine, the current armed conflict in Israel and the Gaza Strip, and the residual impact of the COVID-19 pandemic have led to economic uncertainty. These macroeconomic conditions have and are likely to continue to have adverse effects on the rate of global IT spending, including the buying patterns of the Company’s customers and prospective customers.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents, and marketable securities. The Company deposits its cash and cash equivalents with financial institutions that management believes are of high credit quality, although such deposits may, at times, exceed federally insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents to date. Cash equivalents are invested in highly rated securities. The Company grants credit to customers in the normal course of business. For the three and nine months ended October 31, 2023 and October 31, 2022, there were no individual customers that accounted for 10% or more of the Company’s revenues. No customer accounted for more than 10% of accounts receivable as of October 31, 2023 or January 31, 2023.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the reporting date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. Fair value is estimated by utilizing a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1—Observable inputs comprised of quoted prices for identical assets or liabilities in active markets. Level 2—Inputs other than the quoted prices in active markets that are observable either directly or indirectly. Level 3—Unobservable inputs in which there is little or no market data and that are significant to the fair value of the assets or liabilities. In determining fair value, a financial instrument’s classification within the three-tier fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value. The carrying amount of certain financial instruments, including cash, accounts receivable, accounts payable, and accrued liabilities approximates their fair values due to their short-term nature.
Available-for-sale Investments	Available-for-sale Investments The Company’s marketable securities are primarily comprised of U.S. government securities, commercial paper, and corporate bonds. The Company classifies its securities as available-for-sale at the time of purchase and reevaluates such classification at each balance sheet date. The Company may sell these securities at any time for use in current operations even if they have not yet reached maturity. As a result, the Company classifies its marketable securities, including securities with stated maturities beyond twelve months, within current assets in the condensed consolidated balance sheets. Available-for-sale securities are carried at fair value with unrealized gains and losses reported in accumulated other comprehensive income (loss) as a separate component of stockholders’ equity (deficit) until realized. Unrealized gains and losses for any marketable securities that management intends to sell or is more likely than not that management will be required to sell prior to their anticipated recovery are recorded in other income (expense), net.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company evaluates its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such asset groups may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset group to future undiscounted cash flows expected to be generated by the asset group. If such assets are considered to be impaired, the impairment recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. The Company recorded no impairment charge during the three months ended October 31, 2023 and 2022. The Company recorded $5.0 million and no impairment charge during the nine months ended October 31, 2023 and 2022, respectively. The $5.0 million impairment charge incurred during the nine months ended October 31, 2023 related to the right-of-use (“ROU”) assets and underlying property and equipment associated with the Company’s subleased office spaces is further described in Note 8. Leases to the condensed consolidated financial statements.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements On February 1, 2023, the Company adopted ASU No. 2021-08 , Business Combinations - Accounting for Contract Liabilities from Contracts with Customers, which requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities from acquired contracts using the revenue recognition guidance under Accounting Standards Codification Topic 606 in order to align the recognition of a contract liability with the definition of a performance obligation.

Revenues (Tables)

Revenues (Tables)	9 Months Ended
	Oct. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Deferred Contract Acquisition Costs	The following table summarizes the activity of deferred contract acquisition costs (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Beginning balance $ 38,336 $ 28,227 $ 36,583 $ 22,771 Capitalization of contract acquisition costs 5,277 7,399 17,333 19,427 Amortization of deferred contract acquisition costs (5,668) (3,937) (15,971) (10,509) Ending balance $ 37,945 $ 31,689 $ 37,945 $ 31,689 Deferred contract acquisition costs, current $ 20,528 $ 15,513 $ 20,528 $ 15,513 Deferred contract acquisition costs, noncurrent 17,417 16,176 17,417 16,176 Total deferred contract acquisition costs $ 37,945 $ 31,689 $ 37,945 $ 31,689

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis	The following table summarizes, for assets and liabilities measured at fair value, the respective fair value and classification by level of input within the fair value hierarchy (in thousands): October 31, 2023 Level 1 Level 2 Level 3 Total Current Assets Cash equivalents Money market funds $ 82,400 $ — $ — $ 82,400 Commercial paper — 4,959 — 4,959 U.S. government agency securities 9,950 — — 9,950 Total cash equivalents $ 92,350 $ 4,959 $ — $ 97,309 Marketable securities U.S. government agency securities $ 157,746 $ — $ — $ 157,746 Commercial paper — 11,463 — 11,463 Corporate bonds — 71,279 — 71,279 Agency bonds — 21,238 — 21,238 Total marketable securities $ 157,746 $ 103,980 $ — $ 261,726 Total assets $ 250,096 $ 108,939 $ — $ 359,035 January 31, 2023 Level 1 Level 2 Level 3 Total Current Assets Cash equivalents Money market funds $ 289,001 $ — $ — $ 289,001 Total cash equivalents $ 289,001 $ — $ — $ 289,001 Marketable securities Corporate bonds $ — $ 2,739 $ — $ 2,739 Total marketable securities $ — $ 2,739 $ — $ 2,739 Total assets $ 289,001 $ 2,739 $ — $ 291,740
Schedule of Debt Securities, Available-for-sale	The following table summarizes the Company's investments in marketable securities on the condensed consolidated balance sheets (in thousands): October 31, 2023 Amortized Gross Gross Unrealized Losses Estimated Current Assets U.S. government agency securities $ 158,742 $ 4 $ (1,000) $ 157,746 Commercial paper 11,472 — (9) 11,463 Corporate bonds 71,518 35 (274) 71,279 Agency bonds 21,250 — (12) 21,238 Total marketable securities $ 262,982 $ 39 $ (1,295) $ 261,726 January 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Current Assets Corporate bonds $ 2,744 $ — $ (5) $ 2,739 Total marketable securities $ 2,744 $ — $ (5) $ 2,739
Schedule of Contractual Maturities	The following table presents the contractual maturities of the Company’s marketable securities as of October 31, 2023 (in thousands): October 31, 2023 Amortized Cost Estimated Fair Value Due within one year $ 116,425 $ 116,219 Due within one to three years 146,557 145,507 Total $ 262,982 $ 261,726

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Property and Equipment, Net	Property and Equipment, Net Property and equipment, net, consisted of the following (in thousands): October 31, 2023 January 31, 2023 Leasehold improvements $ 100,733 $ 98,264 Capitalized internal-use software 22,203 15,005 Furniture and fixtures 11,676 10,325 Desktop and other computer equipment 2,106 1,804 Construction in progress 26 652 Total gross property and equipment 136,744 126,050 Less: Accumulated depreciation and amortization (38,503) (31,066) Total property and equipment, net $ 98,241 $ 94,984
Schedule of Prepaid Expenses and Other Current Assets	Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): October 31, 2023 January 31, 2023 Deferred contract acquisition costs, current $ 20,528 $ 18,049 Prepaid expenses 20,305 25,134 Other current assets 5,236 5,543 Total prepaid expenses and other current assets $ 46,069 $ 48,726
Schedule of Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): October 31, 2023 January 31, 2023 Accrued payroll liabilities $ 12,972 $ 22,336 Accrued sales and value-added taxes 10,309 13,347 Accrued taxes for fringe benefits 8,509 8,064 Accrued advertising expenses 7,522 10,565 Accrued consulting expenses 3,263 4,076 Other liabilities 23,123 25,100 Total accrued expenses and other current liabilities $ 65,698 $ 83,488

Debt (Tables)

Debt (Tables)	9 Months Ended
	Oct. 31, 2023
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The net carrying amounts of the November 2022 Senior Secured Credit Facility were as follows (in thousands): October 31, 2023 January 31, 2023 Principal $ 47,500 $ 50,000 Accrued interest 301 218 Unamortized loan issuance costs (144) (179) Net carrying amount $ 47,657 $ 50,039 Term loan, current $ 2,801 $ 3,343 Term loan, noncurrent $ 44,856 $ 46,696

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 31, 2023
Leases [Abstract]
Schedule of Operating Lease, Liability, Maturity	Future minimum lease payments (net of tenant improvement receivables) under non-cancelable operating leases with initial lease terms in excess of one year included in the Company’s lease liabilities as of October 31, 2023 are as follows (in thousands): Fiscal year ending January 31, Operating Lease Payments (Net) 2024 $ 9,751 2025 39,469 2026 37,707 2027 38,075 2028 and thereafter 238,501 Total undiscounted operating lease payments $ 363,503 Less: imputed interest (125,730) Total operating lease liabilities $ 237,773
Sublease Payments to be Received	As of October 31, 2023, the future total minimum sublease payments to be received were as follows (in thousands): Fiscal year ending January 31, Sublease Payments to be Received 2024 $ — 2025 1,556 2026 1,919 2027 1,976 2028 and thereafter 3,244 Total sublease income $ 8,695

Net Loss per Share (Tables)

Net Loss per Share (Tables)	9 Months Ended
	Oct. 31, 2023
Earnings Per Share [Abstract]
Calculation of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share (in thousands, except per share data): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Numerator: Net loss $ (61,750) $ (100,905) $ (194,632) $ (312,742) Denominator: Weighted-average shares used in calculating net loss per share, basic and diluted 221,776 204,657 219,094 195,261 Net loss per share, basic and diluted $ (0.28) $ (0.49) $ (0.89) $ (1.60)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The potential shares of common stock that were excluded from the computation of diluted net loss per share for the period presented because including them would have been anti-dilutive are as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Stock options 10,242 12,405 10,242 12,405 Restricted stock units 17,970 12,048 17,970 12,048 Early exercised stock options — 55 — 55 Shares issuable pursuant to the 2020 Employee Stock Purchase Plan 161 160 161 160 Total 28,373 24,668 28,373 24,668

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)	9 Months Ended
	Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Options Activity	Option activity under the Company’s combined stock plans is set forth below (in thousands, except years and per share data): Number of Shares Weighted- Average Exercise Price Weighted- Aggregate Intrinsic Value Balances at January 31, 2023 11,941 $ 2.96 5.1 $ 149,738 Options granted — — Options exercised (1,649) 2.34 Options cancelled (50) 5.42 Balances at October 31, 2023 10,242 $ 3.05 4.4 $ 157,956 Vested and exercisable at October 31, 2023 9,978 $ 3.05 4.4 $ 153,882 Vested and expected to vest at October 31, 2023 10,242 $ 3.05 4.4 $ 157,961
Summary of Weighted-Average Grant-Date Fair Value of Options Granted and Total Intrinsic Value of Options Exercised	The total intrinsic value of options exercised during the periods presented was as follows: Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Aggregate intrinsic value of options exercised (in thousands) $ 4,583 $ 6,531 $ 30,876 $ 47,586
Schedule of RSU Activity	The Company’s RSU activity is set forth below (in thousands, except per share data): Number of Shares Weighted- Average Grant Date Fair Value Aggregate Intrinsic Value Unvested RSUs at January 31, 2023 14,591 $ 27.75 $ 226,145 RSUs granted 11,831 20.18 RSUs vested (5,582) 26.09 RSUs cancelled/forfeited (2,870) 26.12 Unvested RSUs at October 31, 2023 17,970 $ 23.54 $ 331,906 RSUs vested, not yet released at October 31, 2023 856 $ 36.06
Schedule of Stock-Based Compensation Expense	Stock-based compensation for stock-based awards to employees and non-employees in the Company’s condensed consolidated statements of operations for the periods below were as follows (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Cost of revenues $ 413 $ 461 $ 1,177 $ 1,200 Research and development 29,384 25,030 83,928 70,606 Sales and marketing 15,584 15,018 43,438 43,028 General and administrative 7,485 7,482 22,026 21,000 Total stock-based compensation expense $ 52,866 $ 47,991 $ 150,569 $ 135,834
Summary of Unrecognized Compensation Costs, Related to Unvested Awards	Total unrecognized compensation costs related to unvested awards not yet recognized under all equity compensation plans was as follows: October 31, 2023 Unrecognized Expense Weighted-Average Expected Recognition Period Stock options $ 383 3.5 RSUs 389,817 3.0 Total unrecognized stock-based compensation expense $ 390,200 3.0

Interest Income and Other Inc_2

Interest Income and Other Income (Expense), Net (Tables)	9 Months Ended
	Oct. 31, 2023
Other Income and Expenses [Abstract]
Schedule of Interest and Other Income (Expense), Net	Interest income and other income (expense), net consist of the following (in thousands): Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 Interest income $ 6,088 $ 2,264 $ 15,703 $ 3,007 Unrealized losses on foreign currency transactions (1,545) (211) (1,129) (602) Other non-operating expense (1,064) (762) (1,264) (2,624) Total interest income and other income (expense), net $ 3,479 $ 1,291 $ 13,310 $ (219)

Geographic Information (Tables)

Geographic Information (Tables)	9 Months Ended
	Oct. 31, 2023
Segment Reporting [Abstract]
Revenue by Geographic Areas	Revenues Three Months Ended October 31, Nine Months Ended October 31, 2023 2022 2023 2022 United States $ 101,019 $ 85,976 $ 293,234 $ 238,600 International 65,484 55,463 188,135 158,381 Total revenues $ 166,503 $ 141,439 $ 481,369 $ 396,981
Long-lived Assets by Geographic Areas	Long-Lived Assets October 31, 2023 January 31, 2023 United States $ 275,111 $ 265,582 International 5,909 5,591 Total long-lived assets $ 281,020 $ 271,173

Restructuring (Tables)

Restructuring (Tables)	9 Months Ended
	Oct. 31, 2023
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs	The Company has completed payments associated with these restructuring charges in the nine months ended October 31, 2023 and did not incur any restructuring costs during the three and nine months ended October 31, 2023 and 2022. The following table summarizes the Company’s restructuring liabilities (in thousands): Restructuring Liability Beginning balance as of February 1, 2023 $ 873 Charges (benefit) (147) Payments (707) Foreign currency translation adjustment (19) Ending balance as of October 31, 2023 $ —

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Accounting Policies [Abstract]
Asset impairment charge	$ 5	$ 0

Revenues - Narrative (Details)

Revenues - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue recognized	$ 42.5	$ 32.1	$ 208.6	$ 156.3
Revenue, remaining performance obligation, amount	$ 335.1		$ 335.1
Deferred contract acquisition costs, amortization period	3 years		3 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	85%		85%
Revenue, remaining performance obligation, expected timing of satisfaction, period	12 months		12 months

Revenues - Deferred Contract Ac

Revenues - Deferred Contract Acquisition Costs Activity (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Capitalized Contract Costs [Roll Forward]
Beginning balance	$ 38,336	$ 28,227	$ 36,583	$ 22,771
Capitalization of contract acquisition costs	5,277	7,399	17,333	19,427
Amortization of deferred contract acquisition costs	(5,668)	(3,937)	(15,971)	(10,509)
Ending balance	37,945	31,689	37,945	31,689
Deferred contract acquisition costs, current	20,528	15,513	20,528	15,513	$ 18,049
Deferred contract acquisition costs, noncurrent	17,417	16,176	17,417	16,176
Total deferred contract acquisition costs	$ 37,945	$ 31,689	$ 37,945	$ 31,689	$ 36,583

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Hierarchy (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 97,309	$ 289,001
Marketable securities	261,726	2,739
Total assets	359,035	291,740
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	82,400	289,001
U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	9,950
Marketable securities	157,746
Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	71,279	2,739
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	4,959
Marketable securities	11,463
Agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	21,238
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	92,350	289,001
Marketable securities	157,746	0
Total assets	250,096	289,001
Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	82,400	289,001
Level 1 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	9,950
Marketable securities	157,746
Level 1 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
Marketable securities	0
Level 1 | Agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	4,959	0
Marketable securities	103,980	2,739
Total assets	108,939	2,739
Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Level 2 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
Marketable securities	0
Level 2 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	71,279	2,739
Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	4,959
Marketable securities	11,463
Level 2 | Agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	21,238
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Marketable securities	0	0
Total assets	0	0
Level 3 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Level 3 | U.S. government agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
Marketable securities	0
Level 3 | Corporate bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	$ 0
Level 3 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0
Marketable securities	0
Level 3 | Agency bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 0

Fair Value Measurements - Inves

Fair Value Measurements - Investments (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Current assets
Amortized Cost	$ 262,982	$ 2,744
Gross Unrealized Gains	39	0
Gross Unrealized Losses	(1,295)	(5)
Estimated Fair Value	261,726	2,739
U.S. government agency securities
Current assets
Amortized Cost	158,742
Gross Unrealized Gains	4
Gross Unrealized Losses	(1,000)
Estimated Fair Value	157,746
Commercial paper
Current assets
Amortized Cost	11,472
Gross Unrealized Gains	0
Gross Unrealized Losses	(9)
Estimated Fair Value	11,463
Corporate bonds
Current assets
Amortized Cost	71,518	2,744
Gross Unrealized Gains	35	0
Gross Unrealized Losses	(274)	(5)
Estimated Fair Value	71,279	$ 2,739
Agency bonds
Current assets
Amortized Cost	21,250
Gross Unrealized Gains	0
Gross Unrealized Losses	(12)
Estimated Fair Value	$ 21,238

Fair Value Measurements - Contr

Fair Value Measurements - Contractual Maturities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Amortized Cost
Due within one year	$ 116,425
Due within one to three years	146,557
Amortized Cost	262,982
Estimated Fair Value
Due within one year	116,219
Due within one to three years	145,507
Amortized Cost	$ 261,726	$ 2,739

Balance Sheet Components - Prop

Balance Sheet Components - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Property, Plant and Equipment [Line Items]
Total gross property and equipment	$ 136,744	$ 126,050
Less: Accumulated depreciation and amortization	(38,503)	(31,066)
Property and equipment, net	98,241	94,984
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total gross property and equipment	100,733	98,264
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Total gross property and equipment	22,203	15,005
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total gross property and equipment	11,676	10,325
Construction in progress
Property, Plant and Equipment [Line Items]
Total gross property and equipment	26	652
Desktop and other computer equipment
Property, Plant and Equipment [Line Items]
Total gross property and equipment	$ 2,106	$ 1,804

Balance Sheet Components - Narr

Balance Sheet Components - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation and amortization	$ 3.5	$ 3.2	$ 10.4	$ 9.5

Balance Sheet Components - Prep

Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023	Oct. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Deferred contract acquisition costs, current	$ 20,528	$ 18,049	$ 15,513
Prepaid expenses	20,305	25,134
Other current assets	5,236	5,543
Total prepaid expenses and other current assets	$ 46,069	$ 48,726

Balance Sheet Components - Accr

Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued payroll liabilities	$ 12,972	$ 22,336
Accrued sales and value-added taxes	10,309	13,347
Accrued taxes for fringe benefits	8,509	8,064
Accrued advertising expenses	7,522	10,565
Accrued consulting expenses	3,263	4,076
Other liabilities	23,123	25,100
Total accrued expenses and other current liabilities	$ 65,698	$ 83,488

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)	1 Months Ended		9 Months Ended
	Nov. 30, 2022	Apr. 30, 2020	Oct. 31, 2023	Jan. 31, 2023
Line of Credit Facility [Line Items]
Line of credit, remaining borrowing capacity			$ 78,600,000
Debt issuance costs, net	$ 400,000
Credit Agreement
Line of Credit Facility [Line Items]
Debt instrument, term (in years)	4 years
Debt outstanding			47,500,000	$ 50,000,000
Debt issuance costs, net			144,000	$ 179,000
Credit Agreement | Revolving Credit Facility | Minimum
Line of Credit Facility [Line Items]
Debt instrument, covenant, consolidated adjusted quick ratio	1
Credit Agreement | Revolving Credit Facility | Maximum
Line of Credit Facility [Line Items]
Debt instrument, covenant, consolidated adjusted quick ratio	1.25
Credit Agreement | Letter of Credit
Line of Credit Facility [Line Items]
Line of credit, maximum borrowing facility	$ 30,000,000
Secured Debt | Term Loan Agreement
Line of Credit Facility [Line Items]
Long-term debt, term (in years)		5 years
Long-term debt, face amount		$ 40,000,000
Secured Debt | Term Loan Agreement | Prime Rate | Minimum
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate		0%
Secured Debt | Term Loan Agreement | Prime Rate | Maximum
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate		(1.00%)
Secured Debt | Credit Agreement
Line of Credit Facility [Line Items]
Proceeds from term loan, net of issuance costs			50,000,000
Debt outstanding			47,500,000
Line of Credit | Credit Agreement
Line of Credit Facility [Line Items]
Line of credit, maximum borrowing facility	150,000,000
Line of Credit | Credit Agreement | Term Loan Facility
Line of Credit Facility [Line Items]
Long-term debt, face amount	$ 50,000,000
Debt instrument, basis spread on variable rate	2.25%
Line of Credit | Credit Agreement | Revolving Credit Facility
Line of Credit Facility [Line Items]
Line of credit, maximum borrowing facility	$ 100,000,000
Line of credit facility, commitment fee percentage	0.15%
Letters of credit outstanding, amount			$ 21,400,000
Debt issuance costs, net	$ 200,000
Line of Credit | Credit Agreement | ABR Loans
Line of Credit Facility [Line Items]
Convertible notes, interest rate, stated percentage	1.25%
Line of Credit | Credit Agreement | Secured Overnight Financing Rate (SOFR) | Term Loan Facility
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate	0.10%

Debt - Net Carrying Amount of T

Debt - Net Carrying Amount of Term Loan (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023	Nov. 30, 2022
Debt Instrument [Line Items]
Unamortized loan issuance costs			$ (400)
Credit Agreement
Debt Instrument [Line Items]
Principal	$ 47,500	$ 50,000
Accrued interest	301	218
Unamortized loan issuance costs	(144)	(179)
Net carrying amount	47,657	50,039
Credit Agreement | Term Loan Facility
Debt Instrument [Line Items]
Term loan, current	2,801	3,343
Term loan, noncurrent	$ 44,856	$ 46,696

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	1 Months Ended
	Jan. 31, 2021	Oct. 31, 2023
Other Commitments [Line Items]
Long-term purchase commitment, period	60 months
Minimum spending amount	$ 103.5
Purchase commitment, maximum offsetting amount		$ 7.3
Hosting-Related Services
Other Commitments [Line Items]
Purchase commitment remaining		$ 42.3

Leases - Future Minimum Lease P

Leases - Future Minimum Lease Payments (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Leases [Abstract]
2024	$ 9,751
2025	39,469
2026	37,707
2027	38,075
2028 and thereafter	238,501
Total undiscounted operating lease payments	363,503
Less: imputed interest	(125,730)
Total operating lease liabilities	$ 237,773

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Leases [Abstract]
Impairment of long-lived assets			$ 5,000	$ 0
Sublease term (in years)	5 years		5 years
Sublease income	$ 400	$ 0	$ 400	$ 0
Total sublease income	$ 8,695		$ 8,695

Leases - Sublease Payments to b

Leases - Sublease Payments to be Received (Details) $ in Thousands	Oct. 31, 2023 USD ($)
Leases [Abstract]
2024	$ 0
2025	1,556
2026	1,919
2027	1,976
2028 and thereafter	3,244
Total sublease income	$ 8,695

Net Loss per Share (Details)

Net Loss per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Numerator:
Net loss	$ (61,750)	$ (100,905)	$ (194,632)	$ (312,742)
Denominator:
Weighted-average shares used in calculating net loss per share, basic (in shares)	221,776	204,657	219,094	195,261
Weighted-average shares used in calculating net loss per share, diluted (in shares)	221,776	204,657	219,094	195,261
Net loss per share, basic (in dollars per share)	$ (0.28)	$ (0.49)	$ (0.89)	$ (1.60)
Net loss per share, diluted (in dollars per share)	$ (0.28)	$ (0.49)	$ (0.89)	$ (1.60)

Net Loss per Share - Antidiluti

Net Loss per Share - Antidilutive Securities (Details) - shares	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities (in shares)	28,373,000	24,668,000	28,373,000	24,668,000
Stock options
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities (in shares)	10,242,000	12,405,000	10,242,000	12,405,000
Restricted stock units
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities (in shares)	17,970,000	12,048,000	17,970,000	12,048,000
Early exercised stock options
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities (in shares)	0	55,000	96	55,351
Shares issuable pursuant to the 2020 Employee Stock Purchase Plan
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities (in shares)	161,000	160,000	161,000	160,000

Stockholders' Deficit - Narrati

Stockholders' Deficit - Narrative (Details) $ / shares in Units, $ in Thousands			1 Months Ended		3 Months Ended		9 Months Ended
	Feb. 01, 2023 shares	Feb. 01, 2022 shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2020 purchasePeriod shares	Oct. 31, 2023 USD ($) stockClass shares	Oct. 31, 2022 USD ($) shares	Oct. 31, 2023 USD ($) vote stockClass shares	Oct. 31, 2022 USD ($) shares	Jan. 31, 2023 USD ($) shares	Feb. 01, 2021 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of classes of common stock | stockClass					2		2
Common stock, shares authorized (in shares)					1,500,000,000		1,500,000,000
Options, period increase (decrease) (in shares)	10,714,637	9,414,923
Share-based compensation, options, outstanding (in shares)					10,242,000		10,242,000		11,941,000
Antidilutive securities (in shares)					28,373,000	24,668,000	28,373,000	24,668,000
Share-based payment arrangement, offering period (in months)				24 months
Total stock-based compensation expense | $					$ 52,866	$ 47,991	$ 150,569	$ 135,834
Employee contributions withheld | $					2,500		2,500		$ 6,900
Unrecognized expense | $					$ 390,200		$ 390,200
Early exercised stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Antidilutive securities (in shares)					0	55,000	96	55,351
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, options, outstanding (in shares)					0		0
Share-based compensation, options, issued (in shares)							0
Options, expiration period							10 years
Exercise price, minimum threshold, as a 100% of estimated fair value on the date of grant							100%
Vesting period							4 years
Stock options | Share-based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage							25%
Stock options | Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage							2.08%
Restricted stock units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period							4 years
Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares reserved for future issuance (in shares)				2,000,000
Increase in authorized share amount (in shares)	7,640,712	5,497,785								3,614,801
Share-based payment arrangement, maximum employee subscription rate				15%
Purchase price of common stock, percent				85%
Share-based payment arrangement, offering period (in months)				6 months
Share-based payment arrangement, number of purchase periods | purchasePeriod				4
Share-based payment arrangement, look-back feature, term (in years)				2 years
Total stock-based compensation expense | $					$ 4,500	$ 4,300	$ 7,800	$ 8,000
Unrecognized expense | $					$ 14,800		$ 14,800
Unrecognized expense, period for recognition							1 year 2 months 12 days
Common Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)					1,000,000,000		1,000,000,000
Number of votes per share | vote							1
Conversion of stock, shares converted (in shares)							1
Common stock, shares issued (in shares)					136,915,067		136,915,067		128,803,395
Common stock, shares outstanding (in shares)					136,915,067		136,915,067
Common Class A | Private Placement, Related Party
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issuance of common stock upon private placement—related party, net of issuance costs (in shares)			19,273,127
Shares issued, price per share (in USD per share) | $ / shares			$ 18.16
Sale of stock, consideration received on transaction, gross | $			$ 350,000
Payment of stock issuance costs | $			$ 2,700
Common Class B
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)					500,000,000		500,000,000
Number of votes per share | vote							10
Common stock, shares issued (in shares)					85,489,359		85,489,359		85,489,359
Common stock, shares outstanding (in shares)					85,489,359		85,489,359

Stockholders' Deficit - Schedul

Stockholders' Deficit - Schedule of Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Number of Shares
Beginning balance (in shares)			11,941
Options granted (in shares)			0
Options exercised (in shares)			(1,649)
Options canceled (in shares)			(50)
Ending balance (in shares)	10,242		10,242		11,941
Vested and exercisable, end of period (in shares)	9,978		9,978
Vested and expected to vest, end of period (in shares)	10,242		10,242
Weighted- Average Exercise Price
Beginning balance (in dollars per share)			$ 2.96
Options granted (in dollars per share)			0
Options exercised (in dollars per share)			2.34
Options canceled (in dollars per share)			5.42
Ending balance (in dollars per share)	$ 3.05		3.05		$ 2.96
Vested and exercisable, end of period (in dollars per share)	3.05		3.05
Vested and expected to vest, end of period (in dollars per share)	$ 3.05		$ 3.05
Stock Options Additional Disclosures
Weighted- Average Remaining Contractual Term (in years)			4 years 4 months 24 days		5 years 1 month 6 days
Weighted average remaining contractual term, vested and exercisable (in years)			4 years 4 months 24 days
Weighted average remaining contractual term, vested and expected to vest (in years)			4 years 4 months 24 days
Aggregate intrinsic value, outstanding	$ 157,956		$ 157,956		$ 149,738
Aggregate intrinsic value, vested and exercisable	153,882		153,882
Aggregate intrinsic value, vested and expected to vest	157,961		157,961
Aggregate intrinsic value of options exercised (in thousands)	$ 4,583	$ 6,531	$ 30,876	$ 47,586

Stockholders' Deficit - Sched_2

Stockholders' Deficit - Schedule of RSU Activity (Details) - Restricted stock units - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Oct. 31, 2023	Jan. 31, 2023
Number of Shares
Beginning Balance (in shares)	14,591
RSUs granted (in shares)	11,831
RSUs vested (in shares)	(5,582)
RSUs cancelled/forfeited (in shares)	(2,870)
Ending Balance (in shares)	17,970
RSUs vested, not released (in shares)	856
Weighted- Average Grant Date Fair Value
Beginning Balance (in dollars per share)	$ 27.75
RSUs granted (in dollars per share)	20.18
RSUs vested (in dollars per share)	26.09
RSUs cancelled/forfeited (in dollars per share)	26.12
Ending Balance (in dollars per share)	23.54
RSUs vested, not released (in dollars per share)	$ 36.06
Aggregate Intrinsic Value	$ 331,906	$ 226,145

Stockholders' Deficit - Stock-b

Stockholders' Deficit - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 52,866	$ 47,991	$ 150,569	$ 135,834
Unrecognized expense, stock options	383		383
Unrecognized expense, RSUs	389,817		389,817
Total unrecognized stock-based compensation expense	390,200		$ 390,200
Weighted-Average Expected Recognition Period (in years)			3 years
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-Average Expected Recognition Period (in years)			3 years 6 months
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-Average Expected Recognition Period (in years)			3 years
Cost of revenues
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	413	461	$ 1,177	1,200
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	29,384	25,030	83,928	70,606
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	15,584	15,018	43,438	43,028
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 7,485	$ 7,482	$ 22,026	$ 21,000

Interest Income and Other Inc_3

Interest Income and Other Income (Expense), Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Other Income and Expenses [Abstract]
Interest income	$ 6,088	$ 2,264	$ 15,703	$ 3,007
Unrealized losses on foreign currency transactions	(1,545)	(211)	(1,129)	(602)
Other non-operating expense	(1,064)	(762)	(1,264)	(2,624)
Interest income and other income (expense), net	$ 3,479	$ 1,291	$ 13,310	$ (219)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Income tax expense	$ 796	$ 631	$ 2,946	$ 2,786

Geographic Information (Details

Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 166,503	$ 141,439	$ 481,369	$ 396,981
Long-lived assets	281,020		281,020		$ 271,173
United States
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	101,019	85,976	293,234	238,600
Long-lived assets	275,111		275,111		265,582
International
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	65,484	$ 55,463	188,135	$ 158,381
Long-lived assets	$ 5,909		$ 5,909		$ 5,591

Restructuring (Details)

Restructuring (Details)	Nov. 15, 2022
Restructuring and Related Activities [Abstract]
Restructuring and related cost, number of positions eliminated, period percent	9%

Restructuring - Restructuring a

Restructuring - Restructuring and Related Costs (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2023 USD ($)
Restructuring Reserve [Roll Forward]
Beginning balance as of February 1, 2023	$ 873
Charges (benefit)	(147)
Payments	(707)
Foreign currency translation adjustment	(19)
Ending balance as of October 31, 2023	$ 0

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Lease Expense
Related Party Transaction [Line Items]
Amount of related party transactions	$ 0.3	$ 0.5	$ 1.2	$ 1.4
Advertising Expense One
Related Party Transaction [Line Items]
Amount of related party transactions	0.3	0.5	0.8	1.5
Advertising Agreement Two
Related Party Transaction [Line Items]
Amount of related party transactions	$ 0.5	$ 0.7	$ 1.5	$ 2.5